Vor Biopharma picks up $110m Series B

Cambridge, Massachusetts-based Vor Biopharma, an oncology company, has raised $110 million in a Series B financing. RA Capital Management led the round with participation from other investors that included Fidelity Management & Research Company, LLC, Pagliuca Family Office, Alexandria Venture Investments, 5AM Ventures, Johnson & Johnson Innovation — JJDC, Inc., Osage University Partners and PureTech Health.

Source: Press Release